1. Associations of anticoagulant use with outcome in newly diagnosed glioblastoma. (September 2018) Authors: Le Rhun, Emilie; Genbrugge, Els; Stupp, Roger; Chinot, Olivier L.; Nabors, L. Burt; Cloughesy, Timothy; Reardon, David A.; Wick, Wolfgang; Gorlia, Thierry; Weller, Michael Journal: European journal of cancer Issue: Volume 101(2018) Page Start: 95 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Bevacizumab, temozolomide, and radiotherapy for newly diagnosed glioblastoma: comprehensive safety results during and after first-line therapy. Issue 7 (24th January 2016) Authors: Saran, Frank; Chinot, Olivier L.; Henriksson, Roger; Mason, Warren; Wick, Wolfgang; Cloughesy, Timothy; Dhar, Sunita; Pozzi, Emanuela; Garcia, Josep; Nishikawa, Ryo Journal: Neuro-oncology Issue: Volume 18:Issue 7(2016:Jul.) Page Start: 991 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Evaluation of pseudoprogression rates and tumor progression patterns in a phase III trial of bevacizumab plus radiotherapy/temozolomide for newly diagnosed glioblastoma. Issue 10 (1st October 2016) Authors: Wick, Wolfgang; Chinot, Olivier L.; Bendszus, Martin; Mason, Warren; Henriksson, Roger; Saran, Frank; Nishikawa, Ryo; Revil, Cedric; Kerloeguen, Yannick; Cloughesy, Timothy Journal: Neuro-oncology Issue: Volume 18:Issue 10(2016:Oct.) Page Start: 1434 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Phase 1 dose-escalation study of the antiplacental growth factor monoclonal antibody RO5323441 combined with bevacizumab in patients with recurrent glioblastoma. Issue 7 (9th February 2015) Authors: Lassen, Ulrik; Chinot, Olivier L.; McBain, Catherine; Mau-Sørensen, Morten; Larsen, Vibeke Andrée; Barrie, Maryline; Roth, Patrick; Krieter, Oliver; Wang, Ka; Habben, Kai; Tessier, Jean; Lahr, Angelika; Weller, Michael Journal: Neuro-oncology Issue: Volume 17:Issue 7(2015:Jul.) Page Start: 1007 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Temozolomide Plus Bevacizumab in Elderly Patients with Newly Diagnosed Glioblastoma and Poor Performance Status: An ANOCEF Phase II Trial (ATAG). (22nd February 2018) Authors: Reyes‐Botero, Germán; Cartalat‐Carel, Stéphanie; Chinot, Olivier L.; Barrie, Maryline; Taillandier, Luc; Beauchesne, Patrick; Catry‐Thomas, Isabelle; Barrière, Jérôme; Guillamo, Jean‐Sebastien; Fabbro, Michel; Frappaz, Didier; Benouaich‐Amiel, Alexandra; Le Rhun, Emilie; Campello, Chantal; Tennev... Journal: Oncologist Issue: Volume 23:Number 5(2018) Page Start: 524 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Upfront bevacizumab may extend survival for glioblastoma patients who do not receive second-line therapy: an exploratory analysis of AVAglio. Issue 9 (1st September 2016) Authors: Chinot, Olivier L.; Nishikawa, Ryo; Mason, Warren; Henriksson, Roger; Saran, Frank; Cloughesy, Timothy; Garcia, Josep; Revil, Cedric; Abrey, Lauren; Wick, Wolfgang Journal: Neuro-oncology Issue: Volume 18:Issue 9(2016:Sep.) Page Start: 1313 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗